Participants 177 229 5
patients with unresectable pancreatic adenocarcinoma
Participants 686 781 7
Patients with histological/cytological proven inoperable adenocarcinoma of the head of pancreas
Participants 1063 1088 7
25 patients were enrolled
Participants 1090 1123 3
Nineteen patients were randomised
Participants 1125 1179 3
9 to the intravenous and 10 to the intra-arterial arms
